Omeros Corporation Garners $68,200,000 New Funding

  • Feed Type
  • Date
  • Company Name
    Omeros Corporation
  • Mailing Address
    1420 Fifth Avenue Seattle, WA 98101
  • Company Description
    Omeros recognized that a combination of agents acting on multiple molecular targets may be required for optimal therapeutic effect. Omeros’ product candidates are designed to modulate the molecular mechanisms of pathologic conditions rather than just treating their symptoms.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes from the IPO are on file with the company statements at the SEC.
  • M&A Terms